Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Veronica Gillispie"'
Publikováno v:
Obstet Gynecol
OBJECTIVE: To estimate the national pregnancy-associated homicide mortality ratio, characterize pregnancy-associated homicide victims, and compare the risk of homicide in the perinatal period (pregnancy and up to 1 year postpartum) with risk among no
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
Autor:
Jin Hee Kim, Ozgul Muneyyirci-Delale, Alice Wang, Ayman Al-Hendy, Kurt T. Barnhart, Nelson B. Watts, Eve C. Feinberg, Linda D. Bradley, James A. Simon, Sandra Hurtado, Bruce R. Carr, Ran Liu, William D. Schlaff, Veronica Gillispie, Thomas Dayspring, Charlotte D. Owens, David F. Archer
Publikováno v:
Obstetrics and Gynecology
Up to 12 months of elagolix with add-back therapy provided sustained reduction in menstrual blood loss with an acceptable safety profile in women with uterine leiomyomas.
OBJECTIVE: To investigate the safety and efficacy of elagolix, an oral gon
OBJECTIVE: To investigate the safety and efficacy of elagolix, an oral gon
Autor:
Veronica Gillispie, Ryan Abrigo
Publikováno v:
Clinical Approaches to Hospital Medicine ISBN: 9783030951634
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b06a37d113708a1ab15e0cf5bceae6f5
https://doi.org/10.1007/978-3-030-95164-1_18
https://doi.org/10.1007/978-3-030-95164-1_18
Autor:
Eve C. Feinberg, Anthony N. Imudia, David F. Archer, Jin Hee Kim, Kurt T. Barnhart, Ayman Al-Hendy, Veronica Gillispie-Bell, Elizabeth A. Stewart, Linda D. Bradley, Charlotte D. Owens, Ran Liu
Publikováno v:
Journal of women's health (2002). 31(5)
Objective: To assess outcomes of women with uterine fibroids (UFs) and heavy menstrual bleeding (HMB) treated with 300 mg elagolix twice daily plus add-back therapy (E2 1 mg/NETA 0.5 mg once daily)...
Autor:
Veronica Gillispie-Bell
Publikováno v:
Obstetric Anesthesia Digest. 41:163-164
The evidence of racial health disparities is profound. Much attention has been given to the disparity in maternal morbidity and mortality experienced by Black mothers. The disparity in Black lives lost from coronavirus disease 2019 (COVID-19) has fur
Publikováno v:
Obstet Gynecol
Autor:
Kurt T. Barnhart, James A. Simon, Sandra Hurtado, Ozgul Muneyyirci-Delale, Bruce R. Carr, Hui Wang, Elizabeth A. Stewart, William D. Schlaff, Charlotte D. Owens, Eve C. Feinberg, Veronica Gillispie, David F. Archer, Alice Wang, Elizabeth E. Puscheck, Ayman Al-Hendy, Linda D. Bradley
Publikováno v:
American journal of obstetrics and gynecology
BACKGROUND: Uterine fibroids are one of the most common neoplasms found among women globally, with a prevalence of approximately 11 million women in the United States alone. The morbidity of this common disease is significant because it is the leadin
Autor:
Malcolm G. Munro, Ayman Al-Hendy, S. Eichner, Linda D. Bradley, M. Kumar, Z. Xue, J.H. Kim, Veronica Gillispie
Publikováno v:
Journal of Minimally Invasive Gynecology. 27:S7-S8
Study Objective Heavy menstrual bleeding (HMB) associated with uterine fibroids (UF) often leads to anemia, which may cause fatigue and weakness in affected women. This analysis evaluated clinical improvements in menstrual blood loss (MBL), anemia, a